Ambiq Micro Chief Technology Officer Sold Shares Worth Over $3.2M

Ambiq Micro's CTO and Director, Hanson Scott McLean, sold 55,000 shares at weighted average prices of $59.58 to $60.32, totaling $3.28M. He now directly owns 221,226 shares. The sales occurred in multiple transactions on August 26-27, 2026, according to SEC filings.

Original reporting
Published Aug 28, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 29, 2026, 10:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ambiq Micro Chief Technology Officer Sold Shares Worth Over $3.2M — source image
Decision brief

The 30-second read

Low
01

Why it matters

The insider sale provides fresh data for traders monitoring insider sentiment; however, the amount is modest relative to the company's market cap.

02

Market read

Primary disclosure of an insider sale; limited trading relevance beyond short‑term price reaction.

03

What to watch

No accompanying corporate news; the CTO may be reallocating personal assets.

Relevance 4/10Novelty 4/10Timing: post‑market filing

Background

Ambiq Micro is a low‑power semiconductor company listed on Nasdaq (AMBI). The filing is a standard SEC Form 4 disclosure of insider transactions.

Market effects

Minimal impact on the broader semiconductor sector.

Limited to U.S. investors tracking micro‑cap insider activity.

None

Counterpoint

The sale could be a routine diversification rather than a negative signal.

Key entities

  • Hanson Scott McLean

    Chief Technology Officer of Ambiq Micro

  • Ambiq Micro

    NASDAQ-listed semiconductor firm (ticker AMBI)

Related articles

Med

Ambiq Micro, Inc. Q2 2026 Earnings Call Summary

Ambiq Micro reported Q2 2026 results and said revenue rose 90% year over year, driven by stronger Edge AI demand and growth across Apollo II and Apollo IV, with Apollo V more than doubling on a new large customer ramp. Management projected Q3 net sales up ~100% YoY and 2026 revenue about $135M, despite supply constraints limiting shipments. Gross margin expected to improve modestly in 2026.

Med

Ambiq Micro Q2 net loss narrows to US$7.1 million as edge AI sales surge

Ambiq Micro reported Q2 net loss of $7.1 million, or $0.32 per share, narrowing from $8.5 million a year earlier, as revenue rose 89.7% on stronger demand for ultra-low power edge AI chips. Q2 gross profit more than doubled to $15.3 million and gross margin rose to 45%. H1 net loss was $17.3 million. Cash was $366.8 million after a June follow-on raising $167.9 million net proceeds.

$AMBQHighAI 9/10

Ambiq (AMBQ) Q2 2026 Earnings Call Transcript

Ambiq Micro (AMBQ) reported Q2 2026 net sales of $33.9 million, up 89.7% year over year, citing accelerating edge AI demand. Non-GAAP gross margin was 47.2%. Full-year net sales guidance is about $135 million, with Q3 revenue outlook of $36 million to $37 million. Management cited supply constraints limiting order fulfillment and said cash was $366.8 million as of June 30, 2026.

$ADBEMed

Adobe’s New CEO Takes Over in December. Is the Open CFO Search the Bigger Risk?

Adobe Inc. (ADBE) named Anil Chakravarthy as its next CEO, effective December 1, 2026. Shantanu Narayen will transition to executive chair. Stifel reiterated a Hold rating with a $200 price target, implying 25% downside. Q2 revenue was $6.62B, up 13% YoY. The CFO role remains interim. Hedge funds slightly reduced positions. Next earnings report is on September 10.